| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Gen. Counsel & Corp. Secretary | Ordinary Shares | 0 | $0 | $21.00 | 12 Feb 2026 | Direct |
| AVADEL PHARMACEUTICALS PLC | Gen. Counsel & Corp. Secretary | Stock Option (Right to Buy) | 0 | 12 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVDL | AVADEL PHARMACEUTICALS PLC | 12 Feb 2026 | 8 | -$493,416 | 4 | Gen. Counsel & Corp. Secretary | 12 Feb 2026, 17:35 |
| AVDL | AVADEL PHARMACEUTICALS PLC | 05 Mar 2025 | 2 | $0 | 4 | Gen. Counsel & Corp. Secretary | 07 Mar 2025, 16:09 |
| AVDL | AVADEL PHARMACEUTICALS PLC | 30 Apr 2024 | 0 | $0 | 3 | Gen. Counsel & Corp. Secretary | 03 May 2024, 16:30 |